The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy
- PMID: 38137992
- PMCID: PMC10745538
- DOI: 10.3390/microorganisms11122848
The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy
Abstract
The development of many human disorders, including celiac disease (CD), is thought to be influenced by the microbiota of the gastrointestinal tract and its metabolites, according to current research. This study's goal was to provide a concise summary of the information on the contribution of the intestinal microbiota to the CD pathogenesis, which was actively addressed while examining the reported pathogenesis of celiac disease (CD). We assumed that a change in gluten tolerance is formed under the influence of a number of different factors, including genetic predisposition and environmental factors. In related investigations, researchers have paid increasing attention to the study of disturbances in the composition of the intestinal microbiota and its functional activity in CD. A key finding of our review is that the intestinal microbiota has gluten-degrading properties, which, in turn, may have a protective effect on the development of CD. The intestinal microbiota contributes to maintaining the integrity of the intestinal barrier, preventing the formation of a "leaky" intestine. On the contrary, a change in the composition of the microbiota can act as a significant link in the pathogenesis of gluten intolerance and exacerbate the course of the disease. The possibility of modulating the composition of the microbiota by prescribing probiotic preparations is being considered. The effectiveness of the use of probiotics containing Lactobacillus and Bifidobacterium bacteria in experimental and clinical studies as a preventive and therapeutic agent has been documented.
Keywords: celiac disease; gluten; gluten enteropathy; gut microbiota; immune response; intestinal permeability; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Chen Q., Dong L., Li Y., Liu Y., Xia Q., Sang S., Wu Z., Xiao J., Liu L., Liu L. Research advance of non-thermal processing technologies on ovalbumin properties: The gelation, foaming, emulsification, allergenicity, immunoregulation and its delivery system application. Crit. Rev. Food Sci. Nutr. 2023:1–22. doi: 10.1080/10408398.2023.2179969. - DOI - PubMed
-
- Leiby J.S., McCormick K., Sherrill-Mix S., Clarke E.L., Kessler L.R., Taylor L.J., Hofstaedter C.E., Roche A.M., Mattei L.M., Bittinger K., et al. Lack of detection of a human placenta microbiome in samples from preterm and term deliveries. Microbiome. 2018;6:196. doi: 10.1186/s40168-018-0575-4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
